Nursing Body Ranks First In NIH Proposal Success Rate

A research proposal's chances of being funded by the National Institutes of Health vary noticeably, for better or worse, depending on which specific one of the agency's 13 institutes it is assigned to. For example, according to NIH figures released this summer, the National Center for Nursing Research (NCNR) in 1987 funded the highest percentage of proposals that had been approved by its peer reviewers, 61.5%. Meanwhile, the National Institute of Arthritis and Musculoskeletal and Skin Disease fu

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

For example, according to NIH figures released this summer, the National Center for Nursing Research (NCNR) in 1987 funded the highest percentage of proposals that had been approved by its peer reviewers, 61.5%. Meanwhile, the National Institute of Arthritis and Musculoskeletal and Skin Disease funded only 30.8% of the peer-approved requests.

Fiscal 1987 was the first full year for NCNR to give grants; the center was established in the spring of 1986. Among previously established institutes, the National Eye Institute had the highest 1987 award rate, 53.4%. That institute typically funds a large chunk of its approved proposals, having posted the highest award rate seven times in the last 10 years.

Looking at NIH as a whole, 38.3% of the proposals approved by peer reviewers were funded in 1987. Eight of the 13 institutes' award rates fell under 40%, and only two funded more than 45% of their proposals.

During ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies